News

Filter

Ben-Gurion University researchers and Teva develop psoriasis drug

21-03-2013

Researchers at Ben-Gurion University of the Negev (BGU), in collaboration with Israel largest drugmaker…

DermatologicalsImmunologicalsPharmaceuticalResearchTeva Pharmaceutical Industries

Psoriasis drug market set to see strong growth until 2018, reaching a value of $6.7 million

28-09-2011

The psoriasis therapeutics market is forecast to show high growth until 2018 and market research firm…

DermatologicalsGlobalImmunologicalsMarkets & MarketingPharmaceutical

Novartis’ Gleevec shows promise for treating scleroderma

29-03-2011

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients…

DermatologicalsGleevecImmunologicalsNovartisPharmaceuticalResearch

Back to top